BTIG hired a bunch of senior hires in its investment banking and capital markets division. In New York, the firm hired Charles Mather as a managing director within the firm’s capital markets group and Brett Fodero as a director within the TMT investment banking group. In San Francisco the firm brought on managing director Gene Ramirez, director Steven Marder and Matthew McLeod as a vice president also in the TMT Investment Banking Group. The broker also hired Gregory Wade as a managing director in the company’s healthcare investment banking group.
If you’ve gotten a new job or promotion, let us know at onthemove@sourcemedia.com
Mather, with over 20 years in the market, will advise clients on traditional public, private and other alternative capital raising strategies across the consumer, healthcare and TMT sectors. Prior to joining BTIG, he was co-head of equity capital markets and head of the private and alternative capital group at Janney Montgomery Scott. Before that, he was head of the structured equity group at Jefferies and head of the private equity group at Cowen.
Marder, a market vet with over 25-years of experience, was an attorney, entrepreneur, advisor and operating partner at a number of firms including Avista Capital Partners and Morgan Joseph TriArtisan.
Fodero came from BMO Capital Markets, where he served as an equity research analyst focused on the software industry. Previously, he was a member of the software research team at Lazard Capital Markets for more than five years.
McLeod also came from Morgan Joseph TriArtisan as well, where he served as a member of the TMT team for more than four years. He began his career nearly eight years ago as an investment banker at Lazard Freres.
Wade, will advise companies on strategic and capital-raising-related events and transactions across the healthcare industry with a focus on life sciences and medical technology. He was most recently head of business development at Pharmacyclics, Inc., and previously worked as a research analyst at Pacific Growth Equities and its successor firm for 14 years.
Michael Fitzgerald, a top executive in J.P. Morgan’s prime-brokerage sales unit, has departed the bank, people familiar with the matter said. Once one of the more lucrative businesses on Wall Street, prime brokerages have been squeezed in recent years as new regulations have made certain lending and trading activities less profitable.
Nomura has added three people to its prime finance business in the US, hiring hired former Goldman Sachs exec Ryan Donaldson as an executive director responsible for hedge fund financing, while Walt Kingsbery, who was previously at ED&F Man, has also joined as a vice-president to focus on special situations. Nomura executive director Peter Barry has also been moved from Hong Kong to New York to concentrate on the Japanese bank’s North American hedge fund clients trading Asian strategies.
The ISE announced the addition of Eric Levine and Tyler Sorba to the boards of directors of its two exchanges. Additionally, eight non-industry directors, two exchange directors, and the chief executive officer director were re-elected. Levine, a director and head trader of Barclays’ automated volatility trading group, was appointed to represent ISE’s competitive market makers. Sorba is the co-head of automated equity options market making at Morgan Stanley and was elected to represent ISE’s primary market makers.
Cantor Fitzgerald hired a pair of fixed-income middle market sales traders – Kevin Bowen and David Ballard – both as senior vice presidents. Both Bowen and Ballard come from BBVA Compass, will be based in Cantor’s Birmingham office and focuse on the financial institutions, healthcare and government sectors.
Prior to joining Cantor, Bowen and Ballard both served as senior vice president in the financial risk management group at BBVA Compass. Prior to this, the pair also served as vice presidents of institutional investment sales.
